The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Dzeranova L.K.

National Medical Research Center for Endocrinology

Pigarova E.A.

National Medical Research Center for Endocrinology

Perepelova M.A.

National Medical Research Center for Endocrinology

Ivashchenko K.V.

National Medical Research Center for Endocrinology

Tataeva K.M.

National Medical Research Center for Endocrinology

Shutova A.S.

National Medical Research Center for Endocrinology

Derkatch D.A.

National Medical Research Center for Endocrinology

Urusova L.S.

National Medical Research Center for Endocrinology

Bondarenko E.V.

National Medical Research Center for Endocrinology

Beltsevich D.G.

National Medical Research Center for Endocrinology

Roslyakova A.A.

National Medical Research Center for Endocrinology

Platonova N.M.

National Medical Research Center for Endocrinology

Difficulties of diagnosing a clinically silent pheochromocytoma

Authors:

Dzeranova L.K., Pigarova E.A., Perepelova M.A., Ivashchenko K.V., Tataeva K.M., Shutova A.S., Derkatch D.A., Urusova L.S., Bondarenko E.V., Beltsevich D.G., Roslyakova A.A., Platonova N.M.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2025;28(3): 107‑111

Read: 1007 times


To cite this article:

Dzeranova LK, Pigarova EA, Perepelova MA, et al. . Difficulties of diagnosing a clinically silent pheochromocytoma. Russian Journal of Preventive Medicine. 2025;28(3):107‑111. (In Russ.)
https://doi.org/10.17116/profmed202528031107

References:

  1. Young JB, Landsberg L. Catecholamines and the Adrenal Medulla. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams Textbook of Endocrinology. Philadelphia: W.B. Saunders; 1998;665-728. 
  2. Klingler PJ, Fox TP, Menke DM, et al. Pheochromocytoma in an incidentally discovered asymptomatic cystic adrenal mass. Mayo Clinic Proceedings. 2000;75(5):517-520.  https://doi.org/10.4065/75.5.517
  3. Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. Journal of Clinical Endocrinology and Metabolism. 2000;85(2):637-644.  https://doi.org/10.1210/jcem.85.2.6372
  4. McHenry CR. Pheochromocytoma: a clinical enigma. AACE Clinical Case Reports. 2017;3(2):e180-e181. https://doi.org/10.4158/ep161587.co
  5. Geroula A, Deutschbein T, Langton K, et al. Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion. European Journal of Endocrinology. 2019;181(4):409-420.  https://doi.org/10.1530/EJE-19-0159
  6. Rebrova DV, Vorokhobina NV, Imyanitov EN, et al. Clinical and laboratory features of hereditary pheochromocytoma and paraganglioma. Problemy jendokrinologii. 2022;68(1):8-17. (In Russ.). https://doi.org/10.14341/probl12834
  7. Constantinescu G, Preda C, Constantinescu V, et al. Silent pheochromocytoma and paraganglioma: Systematic review and proposed definitions for standardized terminology. Frontiers in Endocrinology. 2022;13:1021420. https://doi.org/10.3389/fendo.2022.1021420
  8. Ahlquist RP. A study of the adrenotropic receptors. American Journal of Physiology. 1948;153(3):586-600.  https://doi.org/10.1152/ajplegacy.1948.153.3.586
  9. Stolk RF, Bakx C, Mulder J, et al. Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines?. Journal of Clinical Endocrinology and Metabolism. 2013;98(3):1100-1106. https://doi.org/10.1210/jc.2012-3669
  10. Patel D, Phay JE, Yen TWF, et al. Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma. Annals of Surgical Oncology. 2020;27(5):1329-1337. https://doi.org/10.1245/s10434-020-08220-3
  11. Bravo E, Fouad-Tarazi F, Rossi G, et al. A reevaluation of the hemodynamics of pheochromocytoma. Hypertension. 1990;15(2 Suppl):I128-I131. https://doi.org/10.1161/01.hyp.15.2_suppl.i128
  12. Streeten DH, Anderson GH Jr. Mechanisms of orthostatic hypotension and tachycardia in patients with pheochromocytoma. American Journal of Hypertension. 1996;9(8):760-769.  https://doi.org/10.1016/0895-7061(96)00057-x
  13. Bel’tsevich DG, Troshina EA, Iukina MI. Pheochromocytoma. Problemy jendokrinologii. 2010;56(1):63-71. (In Russ.). https://doi.org/10.14341/probl201056163-71
  14. Lance JW, Hinterberger H. Symptoms of pheochromocytoma, with particular reference to headache, correlated with catecholamine production. Archives of Neurology. 1976;33(4):281-288.  https://doi.org/10.1001/archneur.1976.00500040065011
  15. Mannelli M, Ianni L, Cilotti A, Conti A. Pheochromocytoma in Italy: a multicentric retrospective study. European Journal of Endocrinology. 1999;141(6):619-624.  https://doi.org/10.1530/eje.0.1410619
  16. Baguet JP, Hammer L, Mazzuco TL, et al. Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients. European Journal of Endocrinology. 2004;150(5):681-686.  https://doi.org/10.1530/eje.0.1500681

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.